Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Deloitte
Fish and Richardson
Johnson and Johnson
Colorcon
Cerilliant
Cipla
US Department of Justice
Accenture

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SODIUM ACETATE ANHYDROUS

« Back to Dashboard

Clinical Trials for Sodium Acetate Anhydrous

Trial ID Title Status Sponsor Phase Summary
NCT00283387 Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Orphan Europe Phase 2 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Mayo Clinic Phase 2 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00302289 B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Completed Science, Toxicology & Technology, San Francisco, California Phase 1 The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.
NCT00302289 B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Completed University of Copenhagen Phase 1 The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Sodium Acetate Anhydrous

Condition Name

Condition Name for Sodium Acetate Anhydrous
Intervention Trials
Healthy 4
Patients Undergoing Screening or Surveillance Colonoscopy 1
Congenital Cytomegalovirus 1
Parkinson's Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Sodium Acetate Anhydrous
Intervention Trials
Pediatric Obesity 1
Rhinitis 1
Obesity 1
Tension-Type Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Sodium Acetate Anhydrous

Trials by Country

Trials by Country for Sodium Acetate Anhydrous
Location Trials
United States 23
United Kingdom 5
Canada 3
Denmark 1
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Sodium Acetate Anhydrous
Location Trials
Utah 2
North Carolina 2
New York 2
Alabama 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Sodium Acetate Anhydrous

Clinical Trial Phase

Clinical Trial Phase for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Completed 11
Unknown status 2
Not yet recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Sodium Acetate Anhydrous

Sponsor Name

Sponsor Name for Sodium Acetate Anhydrous
Sponsor Trials
Ranbaxy Laboratories Limited 2
Ferring Pharmaceuticals 2
University of Alabama at Birmingham 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Sodium Acetate Anhydrous
Sponsor Trials
Other 13
Industry 11
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Citi
AstraZeneca
US Department of Justice
Medtronic
Accenture
Healthtrust
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.